EUCTR2008-004675-22-DE进行中（未招募）1 期
Intravitreal ranibizumab in patients with retinal pigment epithelial detachments secondary to AMD
niversity of Bonn0 个研究点目标入组 20 人开始时间: 2008年9月3日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-patients with AMD and serous PED as determined by fluoresceine and indocyaningreen angiography and optical coherence tomography (OCT)
- •-patients who have a BCVA score between 73 and 24 ETDRS letters
- •-patients with PED = 200 µm as determined by OCT
- •-male or female patients 50 years of age or greater
- •-patients willing and able to comply with all study procedures
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-patients with BCVA < 24 or >73 letters in the study eye
- •-patients previously treated by intravitreal injections of steroids or anti-VEGF agents, or patients previously treated by Verteporfin photodynamic therapy or focal laser photocoagulation
- •-history of uncontrolled glaucoma in the study eye
研究者
相似试验
已完成
不适用
Intravitreal ranibizumab for patients with neovascular age-related macular degeneration with good baseline visual acuityneovascular age-related macular degenerationJPRN-UMIN000015073Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences40
进行中（未招募）
1 期
Injections into the eye (drug Lucentis) in diabetic patients in whom no further treatment is currently available in clinic when they have developed swelling of the centre of the macula associated with lack of blood supply.Ischaemic Diabetic Macular OedemaMedDRA version: 14.1Level: LLTClassification code 10057915Term: Diabetic macular oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012689Term: Diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012688Term: Diabetic retinal oedemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10054372Term: Diabetic retinal edemaSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10054109Term: Non-proliferative diabetic retinopathySystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: PTClassification code 10012661Term: Diabetic eye diseaseSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: LLTClassification code 10038925Term: Retinopathy diabeticSystem Organ Class: 10015919 - Eye disordersMedDRA version: 14.1Level: HLGTClassification code 10012653Term: Diabetic complicationsSystem Organ Class: 10014698 - Endocrine disordersMedDRA version: 14.1Level: HLTClassification code 10012657Term: Diabetic complications ophthalmicSystem Organ Class: 10014698 - Endocrine disordersEUCTR2013-000031-27-GBMoorfields Eye Hospital80
尚未招募
4 期
Prospective study of Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration in Japanese PatientsExudative Age-Related Macular DegenerationJPRN-UMIN000027799Akita University Department of Ophthalmology50
招募中
不适用
The effect of intravitreal ranibizumab on systemic hypertension in age-related macular degeneration patients with hypertension.age-related macular degenerationJPRN-UMIN000013240Institute of Health Biosciences, The University of Tokushima Graduate School80
已完成
不适用
Comparison of intravitreal ranibizumab injection with or without tissue plasminogen activator in the treatment of type 2 choroidal neovascularizationeovascular age-related macular degenerationJPRN-UMIN000017081Department of Ophthalmology and Visual Science Nagoya City University Graduate School of Medical Sciences20